Back to search

Article

Use of AXL-specific CAR T cells to treat non-small-cell lung cancer

2021-02-16

Abstract excerpt

<title>Abstract</title> <p>The application of Chimeric antigen receptor (CAR) T cells in solid tumors is hindered by lack of tumor specific targets and inefficient T cell infiltration in tumor. It has been postulated that AXL may be an ideal immunotherapy target for non-small-cell lung cancer (NSCLC). Here, we screened 208 non-tumor samples from 22 types of human organs or tissues and 90 tumor samples from NSCLC...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
649685d2-6a0f-5918-9808-2b83eba79d2a
DOI
10.21203/rs.3.rs-244810/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Use of AXL-specific CAR T cells to treat non-small-cell lung cancerDOI 10.21203/rs.3.rs-244810/v1
Select a neighboring publication to make it the new centre.